Redcliffe Labs Launches MPOX Testing

Redcliffe Labs, a diagnostic service provider with a PAN India presence, has launched advanced MPOX testing capabilities. 

In a press statement on Thursday, the company said that this development marks a significant step in enhancing national preparedness against potential MPOX outbreaks and underscores Redcliffe Labs' commitment to delivering quality diagnostics across India. The company's new MPOX testing services aim to bolster public health defences and demonstrate its ongoing dedication to ensuring India’s right to top-tier diagnostic services.

MPOX, a highly contagious viral disease known for its potential to trigger localised outbreaks, poses a serious threat to public health if not managed effectively. The disease, with reported cases in Africa, Europe, and parts of Asia, underscores the need for early detection and preparedness to prevent widespread transmission.

Redcliffe Labs has assured key health authorities, including Noida's Chief Medical Officer and the Indian Council of Medical Research (ICMR), of its readiness to address potential MPOX cases. The advanced testing facilities will enable swift identification and isolation of cases, ensuring healthcare providers are prepared for increased demand and facilitating timely public communication and education to manage community impact.

Aditya Kandoi, CEO of Redcliffe Labs, stated, "At Redcliffe Labs, we recognise that advanced diagnostics are crucial for effectively managing public health crises. Our commitment to quality diagnostics remains steadfast, and our launch of MPOX testing reflects our proactive stance on future health challenges. We are prepared to collaborate closely with health authorities to ensure community safety."

Dr. Geetanjali Gupta, Director of Technical Operations and Quality Assurance at Redcliffe Labs, added, "MPOX, like other highly contagious viral infections, requires early detection for timely intervention. Early diagnosis is essential to prevent complications, control the spread of the disease, and protect public health. By facilitating prompt identification, we aim to improve patient outcomes and prevent further outbreaks."